These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21950630)

  • 1. Localized bullous pemphigoid induced by photodynamic therapy.
    Rakvit P; Kerr AC; Ibbotson SH
    Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):251-3. PubMed ID: 21950630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy-triggered bullous pemphigoid.
    Kluger N; Jeskanen L; Höök-Nikanne J
    Int J Dermatol; 2017 Feb; 56(2):e41-e42. PubMed ID: 27496523
    [No Abstract]   [Full Text] [Related]  

  • 3. Bullous pemphigoid and related subepidermal autoimmune blistering diseases.
    Olasz EB; Yancey KB
    Curr Dir Autoimmun; 2008; 10():141-66. PubMed ID: 18460884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
    Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
    J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
    Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
    Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
    Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
    Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red light laser photodynamic therapy of Bowen's disease.
    Parlette EC
    J Drugs Dermatol; 2004; 3(6 Suppl):S22-4. PubMed ID: 15624738
    [No Abstract]   [Full Text] [Related]  

  • 9. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy.
    Stables GI; Stringer MR; Robinson DJ; Ash DV
    Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warty and clear-cell Bowen's disease successfully treated with photodynamic treatment.
    Sezer E; Yuksek J
    Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):48-50. PubMed ID: 20070841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma promotion after photodynamic therapy of a suspected Bowen's disease lesion.
    Schreml S; Gantner S; Steinbauer J; Babilas P; Landthaler M; Szeimies RM
    Dermatology; 2009; 219(3):279-81. PubMed ID: 19729877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid.
    Saad RW; Domloge-Hultsch N; Yancey KB; Benson PM; James WD
    Arch Dermatol; 1992 Jun; 128(6):807-10. PubMed ID: 1599268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.
    Gayl Schweitzer V
    Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid induced by PUVA therapy.
    Perl S; Rappersberger K; Födinger D; Anegg B; Hönigsmann H; Ortel B
    Dermatology; 1996; 193(3):245-7. PubMed ID: 8944349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aminolevulinic acid-mediated photodynamic therapy to superficial malignant skin tumors using Super Lizer.
    Hirata Y; Koga S; Fukui N; Yu A; Koshida S; Kosaka Y; Kurokawa T; Moriwaki S
    J Dermatol; 2011 Aug; 38(8):748-54. PubMed ID: 21352331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum from normal elderly individuals contains anti-basement membrane zone antibodies.
    Hachisuka H; Kurose K; Karashima T; Mori O; Maeyama Y
    Arch Dermatol; 1996 Oct; 132(10):1201-5. PubMed ID: 8859031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy.
    Usmani N; Stables GI; Telfer NR; Stringer MR
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S273-6. PubMed ID: 16227107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.
    Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J
    Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.